New diabetes clinical trial: Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Published on: November 28, 2019 at 10:30PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Linagliptin;   Drug: Acarbose
Sponsor:   Boehringer Ingelheim
Not yet recruiting
https://ift.tt/33z1aaq